SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-21-000075
Filing Date
2021-01-13
Accepted
2021-01-13 16:44:57
Documents
2
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2739
2 yliupoa.htm EX-24 9224
  Complete submission text file 0001123292-21-000075.txt   13540
Mailing Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE B300 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

IRS No.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments

Mailing Address ROOM 502-I, WANT WANT PLAZA NO. 211 SHIMEN YI ROAD SHANGHAI F4 200041
Business Address
Liu Ye (Reporting) CIK: 0001840407 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-51122 | Film No.: 21526635